Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01861990 | Valproic Acid in Childhood Progressive Brain Tumors | withdrawn | Phase 1 | 0 | Medical University of South CarolinaOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT01188889 | RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease. | withdrawn | Phase 1 / Phase 2 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 15, 2015 | clinicaltrials |
| NCT02150928 | An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) | withdrawn | Phase 2 | 0 | Jazz PharmaceuticalsINDUSTRY | 1 | May 13, 2015 | clinicaltrials |
| NCT01711580 | Re-irradiation of High Grade Gliomas: a Quality of Life Study | withdrawn | — | 0 | Maastricht Radiation OncologyOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00934076 | Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | May 8, 2015 | clinicaltrials |
| NCT01769911 | Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma | withdrawn | N/A | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | May 7, 2015 | clinicaltrials |
| NCT00498667 | The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma | withdrawn | — | 0 | Rambam Health Care CampusOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT02235324 | Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT00022230 | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Roger Williams Medical CenterOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT00678626 | Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 0 | May 4, 2015 | clinicaltrials |
| NCT00024115 | BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00253526 | Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 28, 2015 | clinicaltrials |
| NCT02159248 | Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation | withdrawn | Phase 1 | 0 | Orlando Health, Inc.OTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00903942 | Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 2 | 0 | University of RochesterOTHER | 1 | Apr 27, 2015 | clinicaltrials |
| NCT00785694 | Recurrence of Bladder Cancer After Transurethral Resection With Hexvix | withdrawn | Phase 4 | 0 | GE HealthcareINDUSTRY | 1 | Apr 24, 2015 | clinicaltrials |
| NCT02082405 | Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Apr 24, 2015 | clinicaltrials |
| NCT00469469 | Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma | withdrawn | Phase 2 | 0 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT00092274 | Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma | withdrawn | Phase 1 / Phase 2 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Apr 21, 2015 | clinicaltrials |
| NCT00093314 | HuMax-CD20 in Chronic Lymphocytic Leukemia | withdrawn | Phase 1 / Phase 2 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Apr 21, 2015 | clinicaltrials |
| NCT02420587 | AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 20, 2015 | clinicaltrials |
| NCT00319332 | A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen | withdrawn | Phase 3 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Apr 17, 2015 | clinicaltrials |
| NCT00666081 | Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies | withdrawn | Phase 1 | 0 | GlaxoSmithKlineINDUSTRY | 0 | Apr 17, 2015 | clinicaltrials |
| NCT00891761 | A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | withdrawn | Phase 3 | 0 | GlaxoSmithKlineINDUSTRY | 2 | Apr 17, 2015 | clinicaltrials |
| NCT01317212 | Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme | withdrawn | Phase 1 | 0 | North Bristol NHS TrustOTHER | 1 | Apr 17, 2015 | clinicaltrials |
| NCT00503763 | Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma(PSMMSS) | withdrawn | Phase 2 | 0 | Meir Medical CenterOTHER | 0 | Apr 16, 2015 | clinicaltrials |
| NCT01801163 | A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC) | withdrawn | Phase 1 | 0 | Indiana UniversityOTHER | 1 | Apr 16, 2015 | clinicaltrials |
| NCT01851408 | Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 15, 2015 | clinicaltrials |
| NCT01882972 | Strength for Health | withdrawn | N/A | 0 | Loyola UniversityOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00242528 | Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma. | withdrawn | Phase 4 | 0 | NovartisINDUSTRY | 0 | Apr 14, 2015 | clinicaltrials |
| NCT00969917 | Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma | withdrawn | Phase 2 | 0 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 14, 2015 | clinicaltrials |
| NCT01065545 | The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia | withdrawn | Phase 1 | 0 | Northwestern UniversityOTHER | 0 | Apr 10, 2015 | clinicaltrials |
| NCT00549835 | Acupuncture for Mucositis Pain in Cancer Care | withdrawn | N/A | 0 | Johns Hopkins UniversityOTHER | 1 | Apr 8, 2015 | clinicaltrials |
| NCT02095847 | High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 8, 2015 | clinicaltrials |
| NCT01153945 | Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum | withdrawn | — | 0 | Meir Medical CenterOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT01274572 | Blood for Immune Response to Provenge® in HRPC | withdrawn | — | 0 | Mary Crowley Medical Research CenterOTHER | 0 | Apr 7, 2015 | clinicaltrials |
| NCT00706953 | A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib | withdrawn | Phase 2 | 0 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Apr 6, 2015 | clinicaltrials |
| NCT01094535 | Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery | withdrawn | N/A | 0 | Columbia UniversityOTHER | 1 | Apr 6, 2015 | clinicaltrials |
| NCT02079272 | REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity)(REBECCA) | withdrawn | N/A | 0 | Sophie JACOBOTHER_GOV | 1 | Apr 6, 2015 | clinicaltrials |
| NCT00322790 | Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study | withdrawn | — | 0 | New Mexico Cancer Research AllianceOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT02310971 | Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | withdrawn | Phase 2 | 0 | Prima BioMed LtdINDUSTRY | 0 | Apr 3, 2015 | clinicaltrials |
| NCT01732432 | Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)(EAOC) | withdrawn | — | 0 | University Hospital, Basel, SwitzerlandOTHER | 0 | Apr 1, 2015 | clinicaltrials |
| NCT00210340 | A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis | withdrawn | Phase 1 | 0 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 0 | Mar 30, 2015 | clinicaltrials |
| NCT00881114 | Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer(PGx-SELECT) | withdrawn | Phase 2 | 0 | Georgetown UniversityOTHER | 0 | Mar 27, 2015 | clinicaltrials |
| NCT01008514 | Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer | withdrawn | Phase 2 | 0 | Ohio State University Comprehensive Cancer CenterOTHER | 0 | Mar 26, 2015 | clinicaltrials |
| NCT01953952 | Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer | withdrawn | Phase 2 | 0 | Radiation Therapy Oncology GroupNETWORK | 1 | Mar 20, 2015 | clinicaltrials |
| NCT00736216 | Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 19, 2015 | clinicaltrials |
| NCT00873600 | Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Mar 19, 2015 | clinicaltrials |
| NCT02059967 | Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC | withdrawn | Phase 1 | 0 | Virginia Commonwealth UniversityOTHER | 0 | Mar 19, 2015 | clinicaltrials |
| NCT00659399 | Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression | withdrawn | Phase 1 | 0 | NYU Langone HealthOTHER | 1 | Mar 18, 2015 | clinicaltrials |
Data updated 24 days agoSource updated May 22, 2015source: clinicaltrials